Group One Trading’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
Other funds holding SPRO
Group One Trading's SPRO Position: Q3 2026 in Review
Group One Trading sold out of Spero Therapeutics (SPRO) in Q3 2026, closing a stake of 10,869 shares — an estimated $14.7K sold.
Group One Trading first reported a position in SPRO in Q4 2018 and held it in 16 quarters. The position peaked at $133K in Q2 2023. 62 funds tracked by Wall St. Rank hold SPRO as of Q3 2026.
- Group One Trading reported no remaining Spero Therapeutics position as of Q3 2026 after selling out during the quarter.
- Group One Trading sold 10,869 Spero Therapeutics shares in Q3 2026, an estimated $14.7K.
- Group One Trading first reported a position in Spero Therapeutics in Q4 2018 and held it in 16 quarters.
- Group One Trading's Spero Therapeutics position peaked at $133K in Q2 2023.
- 62 funds tracked by Wall St. Rank held Spero Therapeutics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.